FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

129494006: Choriogonadotropin alfa (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
208276019 Choriogonadotropin alfa en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
733632011 Choriogonadotropin alfa (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2816521014 Choriogonadotrophin alfa en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3216251000005115 choriogonadotropin alfa da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Choriogonadotropin alfa (substance) Is a Product containing choriogonadotropin (medicinal product) false Inferred relationship Some
Choriogonadotropin alfa (substance) Is a fertilitetsfremmende middel false Inferred relationship Some
Choriogonadotropin alfa (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Human chorionic gonadotropin false Inferred relationship Some
Choriogonadotropin alfa (substance) Is a Human chorionic gonadotropin false Inferred relationship Some
Choriogonadotropin alfa (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Placental hormone (disposition) false Inferred relationship Some
Choriogonadotropin alfa (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Gonadotropin (disposition) true Inferred relationship Some
Choriogonadotropin alfa (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Gonad regulating hormone false Inferred relationship Some
Choriogonadotropin alfa (substance) Is a Recombinant human chorionic gonadotrophin (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Choriogonadotropin alfa 250micrograms injection (pdr for recon)+solvent The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Choriogonadotropin alfa (substance) Inferred relationship Some
Product containing choriogonadotropin alfa (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Choriogonadotropin alfa (substance) Inferred relationship Some 1
choriogonadotropin alfa 250 µg pulver til injektionsvæske, rekonstitution + solvens The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Choriogonadotropin alfa (substance) Inferred relationship Some
choriogonadotropin alfa 1500 IE pulver og solvens til injektionsvæske, opløsning, ampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Choriogonadotropin alfa (substance) Inferred relationship Some
choriogonadotropin alfa 2000 IE pulver og solvens til injektionsvæske, opløsning, ampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Choriogonadotropin alfa (substance) Inferred relationship Some
choriogonadotropin alfa 5000 IE pulver og solvens til injektionsvæske, opløsning, ampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Choriogonadotropin alfa (substance) Inferred relationship Some
choriogonadotropin alfa 10.000 IE pulver og solvens til injektionsvæske, opløsning, ampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Choriogonadotropin alfa (substance) Inferred relationship Some
choriogonadotropin alfa 250 µg injektionsvæske, opløsning, 0,5 ml i fyldt injektionssprøjte The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Choriogonadotropin alfa (substance) Inferred relationship Some
Choriogonadotropin alfa 10,000iu powder for conventional release solution for injection ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Choriogonadotropin alfa (substance) Inferred relationship Some
Choriogonadotropin alfa 1500iu powder for conventional release solution for injection ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Choriogonadotropin alfa (substance) Inferred relationship Some
Choriogonadotropin alfa 2000iu powder for conventional release solution for injection ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Choriogonadotropin alfa (substance) Inferred relationship Some
Choriogonadotropin alfa 5000iu powder for conventional release solution for injection ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Choriogonadotropin alfa (substance) Inferred relationship Some
Product containing precisely choriogonadotropin alfa 250 microgram/0.5 milliliter conventional release solution for injection syringe The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Choriogonadotropin alfa (substance) Inferred relationship Some 1
Product containing precisely choriogonadotropin alfa 250 microgram/0.5 milliliter conventional release solution for injection syringe This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Choriogonadotropin alfa (substance) Inferred relationship Some 1
Product containing choriogonadotropin alfa in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Choriogonadotropin alfa (substance) Inferred relationship Some 1
Product containing only choriogonadotropin alfa (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Choriogonadotropin alfa (substance) Inferred relationship Some 1
Choriogonadotropin alfa only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Choriogonadotropin alfa (substance) Inferred relationship Some 1
Product containing precisely choriogonadotropin alfa 500 microgram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Choriogonadotropin alfa (substance) Inferred relationship Some 1
Product containing precisely choriogonadotropin alfa 500 microgram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Choriogonadotropin alfa (substance) Inferred relationship Some 1

Reference Sets

Description inactivation indicator reference set

Back to Start